Tag Catherine Ni MD

Key points Through the Biologics Price Competition and Innovation act, the US Food and Drug Administration (FDA) has defined a biosimilar as a biologic product that is highly similar to the original product notwithstanding minor differences in clinically inactive components.…

Key points Infliximab is a safe and effective therapy for the treatment of moderate-to-severe psoriasis. The mechanism of action of infliximab is inhibition of tumor necrosis factor-α, thereby inhibiting the inflammatory cascade leading to psoriatic skin lesions. Pivotal trials on…